Daniel K. Spiegelman, Director at MYRIAD GENETICS INC (MYGN), sold 14,284 shares at $28.99 ($414K) on 2021-05-28, disclosed to the SEC on 2021-06-01.
Open-market sale of $414k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.99 | 7,142 | $207K | 50.0% |
| 2 | $28.99 | 7,142 | $207K | 50.0% |
| Total | $28.99 avg | 14,284 | $414K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| BMRN | SELL | 2019-04-03 | $1.2M | — | Filing → |